Clinical Trial Update: Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating tildrakizumab for vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Ilumya (tildrakizumab)

Snippet

Sponsor: Premier Specialists, Australia | Conditions: Skin and Connective Tissue Diseases, Skin Diseases | EARLY_Phase 1 | Status: COMPLETED